For protein±DNA complex crystallization, the choice of the DNA fragment is crucial. With the aim of crystallizing the 31 kDa Fpg DNA-repair enzyme bound to DNA, oligonucleotide duplexes varying in length, sequence, end type and nature of the speci®c DNA target site were used. Crystals of several protein±DNA combinations grew from solutions containing both polyethylene glycol and salt. This systematic crystallization screening followed by optimization of the crystallization conditions by microseeding led to crystals of Fpg bound to a 13 base-pair duplex DNA carrying the 1,3-propanediol abasic site analogue which are suitable for crystallographic analysis. Complete native data sets have been collected to 2.1 A Ê resolution.
For protein±DNA complex crystallization, the choice of the DNA fragment is crucial. With the aim of crystallizing the 31 kDa Fpg DNA-repair enzyme bound to DNA, oligonucleotide duplexes varying in length, sequence, end type and nature of the speci®c DNA target site were used. Crystals of several protein±DNA combinations grew from solutions containing both polyethylene glycol and salt. This systematic crystallization screening followed by optimization of the crystallization conditions by microseeding led to crystals of Fpg bound to a 13 base-pair duplex DNA carrying the 1,3-propanediol abasic site analogue which are suitable for crystallographic analysis. Complete native data sets have been collected to 2.1 A Ê resolution.
Introduction
The bacterial formamidopyrimidine-DNA glycosylase (Fpg or MutM) is one of the enzymes that initiate the base-excision repair pathway. First identi®ed in Escherichia coli as a DNA glycosylase (hydrolysis of the N1±C1 H glycosydic bond) able to remove imidazole ring-opened purines (Fapy residues; Chetsanga & Lindahl, 1979) , Fpg was subsequently reported to bind and remove a wide range of oxidatively damaged bases such as 8-oxoguanine (8-oxoG), one of the major oxidized purine products (Tchou et al., 1991; Czeczot et al., 1991; Hatahet et al., 1994) . Fpg also displays an AP (apurinic/apyrimidic) lyase activity which excizes the resulting AP site. This second reaction occurs through successive 3 Hand 5 H -phosphate cleavages by a -elimination mechanism, leading to a one-nucleoside gap in the DNA (Bailly et al., 1989; . After 3 H -dephosphorylation, DNA polymerase can ®ll in the resulting short single-stranded gap and, ®nally, DNA continuity is restored by the DNA ligase (Lloyd & Lin, 1993) . Thereby, Fpg prevents cell death and spontaneous G6T transversions induced by replication arrests at Fapy residues and by the miscoding 8-oxoG, respectively (Michaels et al., 1991; Castaing et al., 1993) .
fpg genes are highly conserved through a wide range of aerobic bacteria (Boiteux et al., 1987; Duwat et al., 1995; Mikawa et al., 1998) and eukaryotic plants (Murphy & Gao, 1998; Ohtsubo et al., 1998) . These genes encode a 31 kDa monomeric enzyme containing a C-terminal zinc-®nger motif (-Cys-X 2 -Cys-X 16 -Cys-X 2 -Cys-) required for DNA binding (O'Connor et al., 1993; Castaing et al., 1993) and a strictly conserved N-terminal sequence (Pro-Glu-Leu-Pro-Glu-Val-Glu-Thr-) containing the catalytic Pro1. Fpg is a DNA glycosylase/AP lyase distinguished from monofunctional DNA glycosylases by its ability to form a covalent Schiff-base intermediate between the C1 H -aldehyde function of the AP site and the -amino group of the Nterminal proline during the AP lyase process (Zharkov et al., 1997) .
Recently, the crystal structure of the Thermus thermophilus Fpg (TtFpg) was determined at 1.9 A Ê resolution (Sugahara et al., 2000) . TtFpg is composed of two domains with original folds connected by a¯exible hinge. Most of the conserved amino-acid residues in the Fpg family are clustered in a large electropositive cleft formed by the interface between the two Fpg domains. The conserved catalytic N-terminal proline emerges at the bottom of the cleft.
To understand how the protein locates, binds and processes its DNA substrate, we initiated the crystallographic study of abortive complexes between the Fpg protein from Lactococcus lactis (LlFpg) and DNA fragments containing AP-site analogues such as 1,3-propanediol and tetrahydrofuran. These DNA fragments are not substrates for the Fpg AP lyase activity, but constitute high-af®nity ligands (Castaing et al., 1999) .
In this paper, we describe the crystallization strategy which allowed us to obtain crystals of LlFpg±DNA abortive complex diffracting to 2.1 A Ê resolution.
Experimental and results

Protein and DNA preparations
The stability of macromolecules is critical in crystallographic studies. Unfortunately, at high crystallization papers concentrations (up to 3 mg ml À1 ) and 277 K, the puri®ed Fpg protein is slowly cleaved into two inactive peptides. However, this intrinsic instability is more pronounced in the E. coli enzyme (EcFpg) than in its L. lactis homologue (LlFpg). Moreover, we have also observed that P1G-LlFpg (a mutant enzyme with a mutation of Pro1 to glycine in LlFpg) is more stable than the wild-type LlFpg and is still able to bind (B. Castaing, unpublished observations) and to partially process damaged DNA (Zharkov et al., 1997; Sidorkina & Laval, 2000) . Considering these observations, we decided to use P1G-LlFpg for screening the initial crystallization conditions of Fpg±DNA complexes.
To obtain the P1G-LlFpg mutant protein, amino-acid replacement was achieved by PCR using the plasmid pVE1064 as a template (Duwat et al., 1995) and the oligonucleotide primers TCACCCGGG-GAATTACCAGAAGTTGAACCG and CTGATCTAGATTATTTTTGCTGACAA-ACTGG. After SmaI and XbaI digestions, the resulting insert was ligated into the pMAL-c vector (New England Biolabs), previously linearized by XbaI and XmnI digestions. After sequence checking, the recombinant plasmid (pMAL-LP1G) was used to transform TG1 cells. LB medium containing 100 mg ml À1 ampicillin was inoculated with an overnight pre-culture of TG1 transformant cells. After IPTG induction (0.5 mM), P1G-LlFpg was overproduced as a fusion protein between maltose-binding protein (MBP) and P1G-LlFpg (MBP-P1G-LlFpg). Bacteria were then lyzed by several freeze-thaw cycles in the presence of lyzosyme (0.5 mg ml À1 ). After ultracentrifugation clari®cation of the bacterial lysate, MBP-P1G-LlFpg was isolated from the soluble fraction (Fig. 1 . 1 ). After mass spectroscopy and N-terminal micro-sequencing checking, the homogenous P1G-LlFpg (5±10 mg ml À1 ) was stored at 193 K in 10 mM HEPES±NaOH pH 7.6, 100 mM NaCl, 5% glycerol, 5 mM -mercaptoethanol and 0.1 mM phenylmethylsulfonyl¯uoride.
Self-complementary synthetic oligonucleotides (Fig. 2) were purchased from Eurogentec (Belgium). After puri®cation by anion-exchange chromatography on MONO-Q (Pharmacia) and desalting by reverse-phase HPLC on ODS-Ultrasphere (Beckman), the oligonucleotides containing an AP-site analogue were annealed with their complementary strand to produce 12 DNA duplexes.
Systematic crystallization studies
In protein/DNA co-crystallization, the precise choice of DNA fragments is critical because interactions between DNA molecules are often responsible for intermolecular contacts in the crystal. Indeed, in many cases the DNA packs endto-end, forming a pseudo-continuous helix (Anderson et al., 1984; Jordan et al., 1985) . Thus, our strategy consisted of considering as crystallization variables the following DNA features: the length, sequence, recognition site and end nature of the DNA fragments (blunt-ended or sticky-ended). We used as DNA target sites two nonmetabolizable substrate analogues, 1,3propanediol and tetrahydrofuran AP-site derivatives, which are able to form very stable non-covalent complexes with Fpg (Castaing et al., 1992 (Castaing et al., , 1999 . We then empirically selected several 13-mer and 15mer double-stranded oligonucleotides with or without a complementary 3 H or 5 H overhanging base (Fig. 2) . DNA duplexes were mixed with P1G-LlFpg and the 12 resulting complexes were tested for co-crystallization. Each protein±DNA complex solution was concentrated to a ®nal concentration of 5 mg ml À1 with a 1.3-fold molar excess of DNA. Using the sparse-matrix crystallization screening kit (Hampton Research; Jancarik & Kim, 1991) , crystallization was performed by the hanging-drop vapourdiffusion method. An initial systematic screen for crystallization was carried out at 293 K. Under several crystallization conditions and with various DNA/protein combinations, small crystals appeared within few days, whereas under the same conditions the protein alone did not crystallize. In all successful assays, the crystal solutions contained polyethylene glycol (20±30% PEG 4K or 8K) and salt (0.1±0.2 M) within a large pH range (Hampton Research Crystal Screen 1 solutions 6, 9, 10, 15, 17, 18, 22, 40, 42 for the complexes with 13-mer DNA duplexes and solutions 6, 9, 15, 17, 18, 20, 31, 38 for the complexes with 15-mer DNA duplexes). The larger crystals were obtained with complexes between P1G-LlFpg and the 1,3-propanediol AP-site analogue containing blunt-ended 13-mer (sequence 1) or one overhanging base ended 15-mer DNA. Interestingly, no Hampton Research Crystal Screen 1 solutions led to crystals with the complex containing the bluntended 15-mer DNA duplex. When the complexes containing sticky-ended DNA were used, crystallization occurred under different conditions according to whether the DNA ends were 5 H or 3 H overhanging. Thus, all these observations indicate clearly that the nature of the DNA ends plays a critical role in the crystallization process. This systematic crystallization screening also showed the effect of the nature of the SDS±PAGE analysis of the P1G-LlFpg protein puri®cation fractions. Lane VII, molecular mass markers (LMW, Pharmacia). Lanes I±VI correspond to the puri®cation steps described in the text.
Figure 2
Oligonucleotides used for the crystallization assays. AP-site analogue containing strands (up) were annealed with their complementary strands (low) to generate 13-mer and 15-mer DNA duplexes (up/low) with blunt ends or one complementary 3 H or 5 H overhanging base ends. In all DNA duplexes, the 1,3propanediol (X) or tetrahydrofuran (Y) site analogue was opposite the bold cytosine. (1) and (2) indicate the 13-mer sequences used in this study. crystallization papers substrate analogue containing DNA [1,3propanediol (X) or tetrahydrofuran (Y) in 13-mer sequence 1; Fig. 2 ]. Indeed, when the same DNA duplex contained the X or Y site, protein±DNA complexes with the bluntended X-DNA crystallized more easily than those with sticky-ended X-DNA and conversely for Y-DNA. These data suggest that the X-DNA and Y-DNA intrinsic structures and/or those induced by the Fpg binding are not equivalent and generate different crystal packings. This observation can also be correlated with the differential Fpg af®nity for these substrate analogues (for LlFpg, K a = 0.25 and 0.125 nM À1 for X and Y, respectively; Castaing et al., 1999) . Finally, the nature of the sequence (13-mer sequences 1 or 2, Fig. 2 ) appeared to have some effects on the crystallization, but these effects are less spectacular than those related to the other parameters.
The ®rst generation of crystals was used for microseeding experiments to obtain single crystals with dimensions up to 0.1 mm (Fig. 3) . The resulting crystals were then systematically tested at the BM30 beamline of the ESRF. The best conditions (0.1 M Tris±HCl pH 8.5, 0.2 M Li 2 SO 4 or 0.1 M MgCl 2 , 30% PEG 4K) were found for the complex between P1G-LlFpg and the bluntended 13-mer (sequence 1) DNA duplex containing the 1,3-propanediol AP-site analogue. These conditions gave similar crystals to the wild-type enzyme (data not shown). An electrophoresis mobility shift assay (Castaing et al., 1999) of the content of carefully washed and dissolved diffracting crystals demonstrated the presence of the protein± DNA complex (data not shown).
Diffraction data collection
After optimization of the crystallization conditions, the best crystals, obtained in 28% PEG 4K, 0.2 M Li 2 SO 4 and 0.1 M Tris±HCl pH 8.9, were soaked for several seconds in a solution containing 16% glycerol as a cryoprotectant and frozen in liquid nitrogen. Using synchrotron radiation at the BM30 beamline of the ESRF (Grenoble, France), we collected three data sets to 2.1 A Ê resolution at 100 K around the absorption edge of the intrinsic Fpg Zn atom. Diffraction data were processed with DENZO (Otwinowski & Minor, 1997) and scaled with SCALEPACK (Evans, 1993) (Table 1) . Crystals belonged to the monoclinic system with space group P2 1 and unit-cell parameters a = 69.1, b = 62.6, c = 80.7 A Ê , = 104.1 . Assuming two complex molecules to be present in the asymmetric unit, the solvent content was calculated to be about 46%.
Conclusions
Thanks to a systematic crystallization study, we have obtained crystals of LlFpg bound to a DNA fragment containing a model of DNA lesion non-metabolizable by the enzyme. Despite the appearance of crystals in several conditions, only a few of them led to single crystals suitable for X-ray diffraction analysis. Therefore, of 12 DNA duplexes only one (13-mer, blunt ends, X site) led to crystals of diffraction quality. Thus, this systematic study also provides a good example of the striking effects of the nature of DNA on crystallization conditions of protein±DNA complexes.
We were able to collect high-resolution data using synchrotron radiation and are now involved in solving the crystal structure of the Fpg±DNA complex using the molecular-replacement method and/or MAD phasing. 1 Â 0.1 mm) , (c, g, h) large prism-shaped crystals, (d) very thick plates (0.6 Â 0.3 Â 0.15 mm), (e) needle-shaped crystals (0.2 mm). These crystals were obtained with the blunt-ended 13-mer duplex (sequence 1) (b, d, e, f) or with the one base overhanging 15-mer duplexes (crystals a, c, g, h), both containing the 1,3-propanediol abasic site analogue. Crystals of Fpg±15-mer diffracted to 5.0 A Ê and, after crystallization optimization, those obtained with 13-mer diffracted to 2.1 A Ê . Under the same conditions, crystals with similar faces were obtained from the wildtype enzyme. 
